Skip to main content

Table 2 Patient demographic and base line characteristics

From: A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis

Variable

Treatment group

Total

 

Fluconazole treated group with HIV

Fluconazole treated group with partial or complete dentures

Active control

 

Gender, number

    

Male

10

8

7

25

Female

05

5

8

20

Age

    

Mean ± S.D

32 ± 3.5

45 ± 4.5

35 ± 1.5

 

CD4 Count/mm3

Mean ± S.D

172 ± 78

650 ± 150

200 ± 250

 

Pre treatment culture

    

Candida albicans

12

10

13

 

Candida Parapsilosis

-

01

-

 

Candida Dubliniansis

03

04

02

Â